Kaori Sano

Kaori Sano

Auto-generated profile, based on publicly available information

Kaori Sano

Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
SOSeiya Ozono
Seiya Ozono
YZYanzhao Zhang
Yanzhao Zhang
HOHirorka Ode
Hirorka Ode
KSKaori Sano
Kaori Sano
TTToong Seng Tan
Toong Seng Tan
KTKenzo Tokunaga
Kenzo Tokunaga
The causative agent of the COVID-19 pandemic, SARS-CoV-2, is steadily mutating during continuous transmission among humans. Such mutations can occur in the spike (S) protein that binds to the ACE2 receptor and is cleaved by TMPRSS2. However, whether S mutations affect SARS-CoV-2 cell entry remains unknown. Here, we show that naturally occurring S mutations can reduce or enhance cell entry via ACE2 and TMPRSS2. A SARS-CoV-2 S-pseudotyped lentivirus exhibits substantially lower entry than that of SARS-CoV S. Among S variants, the D614G mutant shows the highest cell entry, as supported by structural and binding analyses. Nevertheless, the D614G mutation does not affect neutralization by antisera against prototypic viruses. Taken together, we conclude that the D614G mutation increases cell entry by acquiring higher affinity to ACE2 while maintaining neutralization susceptibility. Based on these findings, further worldwide surveillance is required to understand SARS-CoV-2 transmissibility among humans.

1 September 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
KSKaori Sano
Kaori Sano
DBDisha Bhavsar
Disha Bhavsar
GSGagandeep Singh
Gagandeep Singh
DFDaniel Floda
Daniel Floda
KSKomal Srivastava
Komal Srivastava
Florian KrammerFlorian Krammer
Florian Krammer
Immune responses at the respiratory mucosal interface are critical to prevent respiratory infections but it is unclear to what extent antigen specific mucosal secretory IgA (SIgA) antibodies are induced by mRNA vaccination in humans. Here we analyze paired serum and saliva samples from patients with and without prior coronavirus disease 2019 (COVID-19) at multiple time points pre and post severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccination. Our results suggest mucosal SIgA responses induced by mRNA vaccination are impacted by pre-existing immunity. Indeed, vaccination induced a minimal mucosal SIgA response in individuals without pre-exposure to SARS-CoV-2 while SIgA induction after vaccination was more efficient in patients with a history of COVID-19.

7 January 2022 in Science Advances
Verified
Journal Article
Open access
NINaoko Iwata-Yoshikawa
Naoko Iwata-Yoshikawa
NSNozomi Shiwa
Nozomi Shiwa
TSTsuyoshi Sekizuka
Tsuyoshi Sekizuka
KSKaori Sano
Kaori Sano
AAAkira Ainai
Akira Ainai
NNNoriyo Nagata
Noriyo Nagata
Eosinophilic immunopathology was induced by T H 2-shifted immune response and inadequate neutralizing antibody in BALB/c mice.

1 December 2015 in Virus Research
Verified
Journal Article
Open access
MNMakoto Nagai
Makoto Nagai
TOTsutomu Omatsu
Tsutomu Omatsu
HAHiroshi Aoki
Hiroshi Aoki
YKYoshihiro Kaku
Yoshihiro Kaku
GBGraham Belsham
Graham Belsham
TMTetsuya Mizutani
Tetsuya Mizutani
We identified novel viruses in feces from cattle with diarrhea collected in 2009 in Hokkaido Prefecture, Japan, by using a metagenomics approach and determined the (near) complete sequences of the virus. Sequence analyses revealed that they had a standard picornavirus genome organization, i.e. 5' untranslated region (UTR) - L- P1 (VP4- VP3- VP2- VP1) - P2 (2A- 2B- 2C) - P3 (3A- 3B- 3C-3D) - 3'UTR- poly(A). They are closely related to other unclassified Chinese picornaviruses; bat picornaviruses group 1-3, feline picornavirus, and canine picornavirus, sharing 45.4-51.4% (P1), 38.0-44.9% (P2), and 49.6-53.3% (P3) amino acid identities, respectively. The phylogenetic analyses and detailed genome characterization showed that they, together with the unclassified Chinese picornaviruses, grouped as a cluster for the P1, 2C, 3CD and VP1 coding regions. These viruses had conserved features (e.g. predicted protein cleavage sites, presence of a leader protein, 2A, 2C, 3C, and 3D functional domains), suggesting they have a common ancestor. Reverse-transcription-PCR assays, using specific primers designed from the 5'UTR sequence of these viruses, showed that 23.0% (20/87) of fecal samples from cattle with diarrhea were positive, indicating the prevalence of these picornavirus in the Japanese cattle population in Hokkaido Prefecture. However, further studies are needed to investigate the pathogenic potential and etiological role of these viruses in cattle.

3 February 2024 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
KSKaori Sano
Kaori Sano
MKMiyuki Kimura
Miyuki Kimura
ASAkiko Sataka
Akiko Sataka
HHHideki Hasegawa
Hideki Hasegawa
HTHideki Tani
Hideki Tani
TSTadaki Suzuki
Tadaki Suzuki

7 January 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
NNNoriyo Nagata
Noriyo Nagata
NINaoko Iwata-Yoshikawa
Naoko Iwata-Yoshikawa
KSKaori Sano
Kaori Sano
AAAkira Ainai
Akira Ainai
NSNozomi Shiwa
Nozomi Shiwa
HHHideki Hasegawa
Hideki Hasegawa
The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that began in December 2019. Lymphopenia is a common feature in severe cases of COVID-19; however, the role of T cell responses during infection is unclear. Here, we inoculated six cynomolgus monkeys, divided into two groups according to the CD3+ T cell population in peripheral blood, with two clinical isolates of SARS-CoV-2: one of East Asian lineage and one of European lineage. After initial infection with the isolate of East Asian lineage, all three monkeys in the CD3+ low group showed clinical symptoms, including loss of appetite, lethargy, and transient severe anemia with/without short-term fever, within 14 days post-infection (p.i.). By contrast, all three monkeys in the CD3+ high group showed mild clinical symptoms such as mild fever and loss of appetite within 4 days p.i. and then recovered. After a second inoculation with the isolate of European lineage, three of four animals in both groups showed mild clinical symptoms but recovered quickly. Hematological, immunological, and serological tests suggested that the CD3+ high and low groups mounted different immune responses during the initial and second infection stages. In both groups, anti-viral and innate immune responses were activated during the early phase of infection and re-infection. However, in the CD3+ low group, inflammatory responses, such as increased production of monocytes and neutrophils, were stronger than those in the CD3+ high group, leading to more severe immunopathology and failure to eliminate the virus. Taken together, the data suggest that the peripheral T lymphocyte population is associated with pneumonia severity in cynomolgus monkeys experimentally infected with SARS-CoV-2. Author summary SARS-CoV-2 infection causes an illness with clinical manifestations that vary from asymptomatic or mild to severe; examples include severe pneumonia and acute respiratory distress syndrome. Lymphopenia, which is common in severe COVID-19 cases, is characterized by markedly reduced numbers of CD4+ T cells, CD8+ T cells, B cells, and natural killer cells. Here, we showed that cynomolgus monkeys selected according to the T cell populations in peripheral blood have different outcomes after experimental infection with SARS-CoV-2. These findings will increase our understanding of disease pathogenesis and may facilitate the development of animal models for vaccine evaluation.